Skip to main content

Table 1 Characteristics of study participants

From: Enoxaparin for VTE thromboprophylaxis during inpatient rehabilitation care: assessment of the standard fixed dosing regimen

 

All ( n =63)

SAIS ( n =31)

SCI ( n =32)

p

Age (years) (mean)

59.1±14

63.6±7.7

54.7±17.1

0.01

Male (% of patients)

44 (70%)

23 (74%)

21 (66%)

NS

Height (m) (Median)

1.7 (0.12)

1.69 (0.12)

1.7 (0.13)

NS

Total body weight (kg) (median)

75 (21)

77 (20)

73 (14.9)

NS

BMI (kg/m2) (median)

26 (5.46)

27.6 (4.57)

26.2 (6.17)

NS

Diabetes (% of patients)

30 (48%)

21 (68%)

9 (28%)

0.002

Current smoker (% of patients)

20 (32%)

13 (42%)

7 (22%)

NS

Creatinine (mg/dl) (mean)

0.9±0.2

0.9±0.1

0.8±0.2

NS

CrCl (ml/min) (mean)

96.9±29.3

90.2±21.2

103.3±34.6

NS

  1. Quantitative data are expressed as median and interquartile range or mean±standard deviation as appropriate
  2. BMI Body mass index, CrCl Creatinine clearance computed according to the Cockroft-Gault formula